Cargando…
Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy
BACKGROUND AND PURPOSE: To evaluate the different response patterns after Stereotactic Body Radiation Therapy (SBRT) and their predictive value in local control and progression of hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Seventy-two HCC patients who were treated with SBRT during 2015–2...
Autores principales: | Wu, Qi-Qiao, Chen, Yi-Xing, Du, Shi-Suo, Hu, Yong, Yang, Ping, Zeng, Zhao-Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014333/ https://www.ncbi.nlm.nih.gov/pubmed/36935858 http://dx.doi.org/10.1016/j.ctro.2022.03.010 |
Ejemplares similares
-
Effect of the normal liver mean dose on intrahepatic recurrence in patients with hepatocellular carcinoma after receiving liver stereotactic body radiation therapy
por: Wu, Qi-Qiao, et al.
Publicado: (2022) -
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
por: Su, Ting-Shi, et al.
Publicado: (2016) -
Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
por: Chen, Yi-Xing, et al.
Publicado: (2023) -
Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy
por: Shin, Kyung In, et al.
Publicado: (2020) -
Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma
por: Zhuang, Yuan, et al.
Publicado: (2019)